Open AccessThis article is
- freely available
Opening up the Window into “Chemobrain”: A Neuroimaging Review
Memory and Aging Center, Neurology, UCSF, Sandler Neuroscience Center, 675 Nelson Rising Lane, San Francisco, CA 94158, USA
School of Psychology, University of Ottawa, Vanier Hall, 136 Jean Jacques Lussier, Ottawa, ON K1N 6N5, Canada
* Author to whom correspondence should be addressed.
Received: 1 January 2013; in revised form: 5 February 2013 / Accepted: 16 February 2013 / Published: 6 March 2013
Abstract: As more chemotherapy-treated cancer patients are reaching survivorship, side-effects such as cognitive impairment warrant research attention. The advent of neuroimaging has helped uncover a neural basis for these deficits. This paper offers a review of neuroimaging investigations in chemotherapy-treated adult cancer patients, discussing the benefits and limitations of each technique and study design. Additionally, despite the assumption given by the chemobrain label that chemotherapy is the only causative agent of these deficits, other factors will be considered. Suggestions are made on how to more comprehensively study these cognitive changes using imaging techniques, thereby promoting generalizability of the results to clinical applications. Continued investigations may yield better long-term quality of life outcomes by supporting patients’ self-reports, and revealing brain regions being affected by chemotherapy.
Keywords: chemotherapy; cognitive impairment; chemobrain; neuroimaging; cancer survivorship issues
Citations to this Article
Cite This Article
MDPI and ACS Style
Scherling, C.S.; Smith, A. Opening up the Window into “Chemobrain”: A Neuroimaging Review. Sensors 2013, 13, 3169-3203.
Scherling CS, Smith A. Opening up the Window into “Chemobrain”: A Neuroimaging Review. Sensors. 2013; 13(3):3169-3203.
Scherling, Carole S.; Smith, Andra. 2013. "Opening up the Window into “Chemobrain”: A Neuroimaging Review." Sensors 13, no. 3: 3169-3203.